{"filing":{"accession_number":"0001104659-26-075826","cik":"0001855644","ticker":"ZURA","company_name":"Zura Bio Ltd","form":"8-K","filing_date":"2026-06-18","report_date":null,"primary_document":"tm2618327d1_8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1855644/000110465926075826/tm2618327d1_8k.htm"},"events":[{"id":11971,"run_id":10534,"accession_number":"0001104659-26-075826","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"summary":"Zura Bio held its Annual Meeting of Shareholders on June 17, 2026, with voting results on four proposals: election of eight directors, ratification of WithumSmith+Brown, PC as independent auditor, approval of the Amended 2023 Equity Incentive Plan, and an adjournment proposal. Detailed vote tallies (For/Against/Abstain/Broker Non-Votes) for each proposal are disclosed.","company_name":"Zura Bio Ltd","ticker":"ZURA","filing_date":"2026-06-18","form":"8-K","submitted_at":null,"items":[{"id":8697,"accession_number":"0001104659-26-075826","item_number":"5.02","item_title":null,"event_type":"exec_compensation","event_domain":"governance","is_material":true,"confidence":0.92,"reasoning":"The filing discloses shareholder approval of an amendment and restatement of the Company's 2023 Equity Incentive Plan, effective immediately upon approval at the Annual Meeting on June 17, 2026. This is a compensatory arrangement disclosure under Item 5.02(e), as equity incentive plans are material to executive and employee compensation structures and require shareholder approval.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-18T21:03:37.412631+00:00","company_name":"","ticker":null,"filing_date":""},{"id":8698,"accession_number":"0001104659-26-075826","item_number":"5.07","item_title":null,"event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a classic Item 5.07 disclosure of shareholder vote results from Zura Bio's Annual Meeting held on June 17, 2026. The filing reports voting outcomes on four proposals: election of eight directors, ratification of the independent auditor (WithumSmith+Brown, PC), approval of the Amended 2023 Equity Incentive Plan, and an adjournment proposal. The detailed vote tallies (For/Against/Abstain/Broker Non-Votes) for each proposal are the core content, making this unambiguously a shareholder_vote_results event.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-18T21:03:37.412631+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":8697,"accession_number":"0001104659-26-075826","item_number":"5.02","item_title":null,"event_type":"exec_compensation","event_domain":"governance","is_material":true,"confidence":0.92,"reasoning":"The filing discloses shareholder approval of an amendment and restatement of the Company's 2023 Equity Incentive Plan, effective immediately upon approval at the Annual Meeting on June 17, 2026. This is a compensatory arrangement disclosure under Item 5.02(e), as equity incentive plans are material to executive and employee compensation structures and require shareholder approval.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-18T21:03:37.412631+00:00","company_name":"Zura Bio Ltd","ticker":"ZURA","filing_date":"2026-06-18"},{"id":8698,"accession_number":"0001104659-26-075826","item_number":"5.07","item_title":null,"event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a classic Item 5.07 disclosure of shareholder vote results from Zura Bio's Annual Meeting held on June 17, 2026. The filing reports voting outcomes on four proposals: election of eight directors, ratification of the independent auditor (WithumSmith+Brown, PC), approval of the Amended 2023 Equity Incentive Plan, and an adjournment proposal. The detailed vote tallies (For/Against/Abstain/Broker Non-Votes) for each proposal are the core content, making this unambiguously a shareholder_vote_results event.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-18T21:03:37.412631+00:00","company_name":"Zura Bio Ltd","ticker":"ZURA","filing_date":"2026-06-18"}]}